This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Augmedix, Inc.
8/7/2023
Ladies and gentlemen, greetings and welcome to the Augmedics, Inc. second quarter 2023 earnings conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star and zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Matt Cheslow, Investor Relations for Augmetics. Thank you, and over to you, sir.
Thank you, Operator. Joining me today are Manny Korkaris, Chief Executive Officer of Augmetics, and Paul Ginocchio, Chief Financial Officer. This afternoon, we released financial results for the quarter ended June 30, 2023. We posted a copy of the press release and an investor presentation to our website at Augmetics.com. We will begin our call with prepared remarks to be followed by a Q&A session. This call is also being simulcast and will be archived on our website. Before we begin, I'd like to remind you the management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements that relate to expectations or predictions of future events, results, or performance are forward-looking statements. They are based upon our current estimates and various assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the risks factors and management discussion and analysis in our most recent Form 10-K and Form 10-Q filed with the Securities and Exchange Commission and similar disclosures in subsequent reports filed with the SEC. Also, during our call today, we will discuss non-GAAP financial measures which adjust our GAAP results to eliminate the impact of certain items. You will find additional information regarding these financial measures and the reconciliation to get measures in today's press release. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, August 7, 2023. We disclaim any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise.
And with that, I'll turn the call over to Manny. Thanks, Matt.
You're reading a preview of the AUGX Q2 2023 earnings call.
Free account.